Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Fenretinide × CNS × Clear all

Status

Completed 4 Terminated 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

3-Iodobenzylguanidine 2 tucatinib 1 rindopepimut 1 pembrolizumab 1 pegfilgrastim 1 paclitaxel-Angiopep-2 conjugate 1 omburtamab I-131 1 mogamulizumab 1 fluorodopa F 18 1 efineptakin alfa 1 avapritinib 1 Vorinostat 1 TIC10 compound 1 Potassium Iodide 1 OKN 007 1 Ketoconazole 1 Ipilimumab 1 Granulocyte Colony-Stimulating Factor 1 Fenretinide 1 Cancer Vaccines 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02075177 2022-03-21

Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

South Plains Oncology Consortium

No longer available

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡